MSAC Stock Ownership Activity

MEDICUS SCIENCES ACQUISITI-A 13F holders

No value investing guru has made any change to the MEDICUS SCIENCES ACQUISITI-A (MSAC) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying MSAC now?

According to the latest SEC filing(s) MEDICUS SCIENCES ACQUISITI-A (MSAC) has not been purchased by any super investor.

To see more about who is investing in MEDICUS SCIENCES ACQUISITI-A (MSAC), please go to the MSAC ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2022 Q1 (1 result)
Daniel Loeb
Third Point
-100.00%
-790,000
-0.10%
0.00%
Current price: $10.17 4.63% Reported price*: $9.72
2021 Q2 (1 result)
Daniel Loeb
Third Point
buy
+790,000
+0.04%
0.04%
Current price: $10.17 5.38% Reported price*: $9.65
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.